BRLI Financial Facts
Interest Expense: 300KReagents and Laboratory Supplies: 31.7M
See Full Income Statement
Accounts Receivable - Net: 161.29M
Deferred Tax Assets: 24.39M
See Full Balance Sheet
Earnings History for Bio-Reference Laboratories Inc. (BRLI)
|
Expand Research on BRLI
| Next EPS Date | 6/5/13 *Est. | EPS Growth Rate | +30.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +7.3% | Revenue Growth Rate | +7.6% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/28/13  |
Q113 | $0.34 | $0.28 | +$0.06 | $161.26M | $165.44M | N/A / N/A | N/A | +22.4% | Details | |
| 12/6/12 |
 |
Q412 | $0.46 | $0.46 | $0.00 | $176.05M | $175.46M | $0.44 / $175M | N/A | +14.3% | Details |
| 8/30/12 | Q312 | $0.45 | $0.43 | +$0.02 | $172.3K | $173.7K | $0.43 / $175.03M | N/A | +9.5% | Details | |
| 6/7/12 |
|
Q212 | $0.33 | $0.32 | +$0.01 | $163.4M | $161.48M | N/A / N/A | N/A | +42.3% | Details |
| 3/1/12 |
|
Q112 | $0.26 | $0.21 | +$0.05 | $149.92M | $143.13M | $0.22 / $146.8M | N/A | +55% | Details |
| 12/8/11 |
|
Q411 | $0.37 | $0.35 | +$0.02 | $151.3M | $150.46M | N/A / N/A | N/A | +150.5% | Details |
| 8/25/11 |
|
Q311 | $0.36 | $0.34 | +$0.02 | $148.03M | $146.3M | N/A / N/A | N/A | +65% | Details |
| 5/26/11 | Q211 | $0.26 | $0.25 | +$0.01 | $137.7M | $131.2M | N/A / N/A | N/A | +30.2% | Details |
